During the past 2 years, the number of significant M&A and licensing transactions as increased worldwide and this trend appears set to continue for the foreseeable future. In the pharma and biotech sector, for example, M&A transactions in the first 6 months of 2014 amounted to a remarkable US$87 billion. The principal catalysts for this activity include low interest rates, companies' cash reserves and the desire for growth.
This seminar is intended for Japanese companies that may be contemplating or currently negotiating M&A or other types of transactions, such as licensing, with a focus on Europe and the life sciences sector.
In particular, we will share information gained from our recent international experience and will review: issues to take into account in asset and share deals, current trends in protection mechanisms for buyers and sellers; industry-specific representations, warranties and indemnities, and their relative merits; the impact of insolvency law on licensing transactions; and critical IP issues in M&A and licensing (including employee-inventor issues and the new Technology Transfer Block Exemption Regulation). We hope this will provide practical guidance for Japanese companies and help them execute transactions that are effective, profitable and successful in the long-term.
Hogan Lovells speakers
- Dr Lutz Angerer (Partner, Munich, Head of German Practice Group Corporate/M&A and Co-Head of Global Life Sciences Transactions Team)
- Dr Andreas von Falck (Partner, Düsseldorf and Head of Global Intellectual Property, Media & Technology Practice)
- Dr Frederick Ch'en (Of Counsel, Tokyo)
Monday 1 December 2014
Hogan Lovells Tokyo Office
15F Daido Seimei Kasumigaseki Building.
1-4-2 Kasumigaseki, Chiyoda-ku, Tokyo
T +81 (0)3 5157 8200
14:00-15:00 Seminar – Part1
15:00-15:25 Coffee break
15:25-15:55 Seminar – Part2
Please RSVP via online form (click here) or e-mail email@example.com to sign up, providing the following information.
1. Your company name
2. All of the applicants' full names, in both Japanese & alphabet
* Seats are limited and will be allocated on a first-come, first-served basis.
* Registration will be closed once the maximum seat capacity has been reached.
* Attendance to this seminar is free of charge.